<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>42(11)</volume><submitter>Meng X</submitter><funding>IMPACT Therapeutics</funding><pubmed_abstract>&lt;h4>Background and objectives&lt;/h4>Data on the effect of food on the pharmacokinetics of senaparib (previously IMP4297), an oral poly (adenosine diphosphate-ribose) polymerase inhibitor, are limited. This study was conducted to evaluate the effect of food on the pharmacokinetics of senaparib in healthy Chinese subjects.&lt;h4>Methods&lt;/h4>This is a phase I, open-label, randomized, single-dose, two-way crossover study. Healthy Chinese male subjects were randomized 1:1 to receive a single dose of senaparib 100 mg in two prandial states: fasted or after a high-fat meal; subjects were given a second dose after switching prandial states and a washout period of at least 7 days. Pharmacokinetics were assessed at pre-dose and up to 72 h post-dose. Safety was assessed throughout the study.&lt;h4>Results&lt;/h</pubmed_abstract><journal>Clinical drug investigation</journal><pagination>1009-1016</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9617823</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Effect of Food on the Pharmacokinetics of Senaparib (IMP4297) in Healthy Chinese Subjects.</pubmed_title><pmcid>PMC9617823</pmcid><pubmed_authors>Cao M</pubmed_authors><pubmed_authors>Zhang J</pubmed_authors><pubmed_authors>Lu Y</pubmed_authors><pubmed_authors>Zeng L</pubmed_authors><pubmed_authors>Lin X</pubmed_authors><pubmed_authors>Jiang R</pubmed_authors><pubmed_authors>Meng X</pubmed_authors></additional><is_claimable>false</is_claimable><name>Effect of Food on the Pharmacokinetics of Senaparib (IMP4297) in Healthy Chinese Subjects.</name><description>&lt;h4>Background and objectives&lt;/h4>Data on the effect of food on the pharmacokinetics of senaparib (previously IMP4297), an oral poly (adenosine diphosphate-ribose) polymerase inhibitor, are limited. This study was conducted to evaluate the effect of food on the pharmacokinetics of senaparib in healthy Chinese subjects.&lt;h4>Methods&lt;/h4>This is a phase I, open-label, randomized, single-dose, two-way crossover study. Healthy Chinese male subjects were randomized 1:1 to receive a single dose of senaparib 100 mg in two prandial states: fasted or after a high-fat meal; subjects were given a second dose after switching prandial states and a washout period of at least 7 days. Pharmacokinetics were assessed at pre-dose and up to 72 h post-dose. Safety was assessed throughout the study.&lt;h4>Results&lt;/h</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Nov</publication><modification>2025-04-04T13:31:52.931Z</modification><creation>2025-02-19T04:03:05.994Z</creation></dates><accession>S-EPMC9617823</accession><cross_references><pubmed>36239914</pubmed><doi>10.1007/s40261-022-01198-8</doi></cross_references></HashMap>